POST-TERM LICENSE Sample Clauses

POST-TERM LICENSE. Following expiration or termination of this Agreement, the License shall continue with respect to the Screening Products for which the License has been fully-paid pursuant to Section 3.1. Lilly shall be entitled to [ * ] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 406 OF THE SECURITIES ACT OF 1933, AS AMENDED.
AutoNDA by SimpleDocs
POST-TERM LICENSE. In the event of a termination of this Agreement by Genentech pursuant to Sections 14.3.1 or 14.3.2 or by BioNTech pursuant to Section 14.2, provided that the termination is not due to the demonstration of an unfavorable safety profile of Collaboration Product(s), then upon BioNTech’s written request to be delivered no later than [***] days following the delivery of a notice of termination by Genentech under Section 14.3.1 or 14.3.2 or by BioNTech under Section 14.2 (“Post-Term License Notice”), Genentech shall grant to BioNTech pursuant to a separate written agreement [***] If Genentech and BioNTech have not entered into such agreement until the effective date of termination, [***]
POST-TERM LICENSE. Following expiration or termination of this Agreement, the product license granted to Amgen under Section 2.1 shall continue to be fully-paid, irrevocable and perpetual and, in addition, Amgen shall be entitled to continue to purchase such Instruments, LabChips and other Screening Products for so long as Caliper continues to offer such items for sale to third parties. Caliper will notify Amgen before ceasing production of any Screening Product which Amgen has purchased in the [ * ] period before production is due to cease. The know-how license granted under Section 2.1 shall continue to be fully-paid, irrevocable and perpetual with respect to Caliper Know-How provided to Amgen during the Term. The non-exclusive license granted to Amgen under Section 4.2 shall continue to be royalty-free, irrevocable and perpetual with respect to Caliper Technology and LabChip Improvements covered thereby. [ * ] = CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY BRACKETS, HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 406 OF THE SECURITIES ACT OF 133, AS AMENDED.
POST-TERM LICENSE. Upon the termination of this Agreement ----------------- for any reason other than termination by MP as a result of AOL's uncured material breach of this Agreement (including but not limited to Exhibit C hereto), MP shall permit AOL to continue to license all intellectual property licensed pursuant to this Agreement (including without limitation the Licensed Data and all functionality supplied in connection with the Buying Service) for a period of [ ** ] (or such shorter period as AOL shall determine) (the "Post-Term License Period"), provided that AOL shall pay to MP from the date of termination of the Agreement and continuing until the termination of the Post-Term License Period, a monthly license fee in advance of [ ** ] per month. Notwithstanding any provision of this Agreement to the contrary, this Section 4.1.2 shall survive any termination of this Agreement.
POST-TERM LICENSE. Upon the expiration or earlier termination of this Agreement, and provided that as of such expiration or earlier termination Supplier is not in material breach of any of its obligations under this Agreement or any other contracts with Stryker or any of its Affiliates, Stryker will enter into a license agreement with Supplier, pursuant to which Stryker will grant to Supplier a worldwide, non-exclusive, non-transferrable, royalty-free license to the know-how and trade secrets included in the Stryker Technology as of the “Closing” under the Purchase Agreement and listed in Schedule 1.1(d) of the Purchase Agreement that are associated with the manufacture and design of ultrasonic accessory tips. Such license agreement will contain other customary terms and obligations.
POST-TERM LICENSE. Following the expiration or termination of the Term, upon the School’s written request, it may continue to use, and to that end Manager shall agree to extend the I.P. License, solely with respect to Manager’s copyrighted materials (e.g., Manager’s curriculum, teaching materials, handouts, protocols, policies, and teacher-training documents), for the purpose of the School continuing to operate its school with no significant academic disruptions. To ensure the validity and enforceability of this limited, post-Term I.P. License, the School shall pay an annual licensing fee to Manager of [Forty Thousand Dollars ($40,000)], due and payable no later than by November 1st of each year (with respect to the fiscal year which began on the immediately-preceding July 1st).
POST-TERM LICENSE. Following expiration or termination of this Agreement, the licenses granted to MPI under Sections 2.1 and 3.1.1
AutoNDA by SimpleDocs

Related to POST-TERM LICENSE

  • Technology License 4.1 Unless any event described in Article 2.2 or 2.3 of this Agreement occurs, all of the technology required to be licensed for any of Party B’s business shall be provided by Party A on an exclusive basis. Party A will try its best to license Party B to use the technology owned by Party A, or re-license Party B to use the technology as approved by the owner. 4.2 The Parties shall negotiate with each other to enter into specific technology license contracts to expressly specify the detail matters such as the technology to be licensed, the method to license the technology, license fees and payment.

  • Research License Each Collaborator shall allow the other Collaborator to practice any of its Non- Subject Inventions for the purpose of performing the Cooperative Work. No license, express or implied, for commercial application(s) is granted to either Collaborator in Non-Subject Inventions by performing the Cooperative Work. For commercial application(s) of Non-Subject Inventions, a license must be obtained from the owner.

  • Development License Subject to the terms and conditions of this XXXX, You are licensed to perform an installation of the SOFTWARE for an unlimited use in designing, testing and creating Developed Software by unlimited Developers on one or more computers.

  • The License 3.1.1 Subject to and in accordance with the terms and conditions set forth in this Agreement, and in particular subject to the due fulfillment of all the obligations assumed towards Maha-Metro by the Licensee, Maha-Metro hereby grants and authorizes the Licensee to the following (the “Specified Purpose”) : a. To have access to Licensed Space(s) during the License Period, develop, finance, commission, operate, manage and maintain the Licensed Space(s) during the License Period at the cost and risk of the Licensee. Any development made by the Licensee on the Licensed Space(s) shall be deemed to be the property of Maha-Metro and all the rights of the Licensee in the Licensed Space(s) shall relinquish in the favour of Maha-Metro. b. Subsequent to the Fitment Period, to utilise the licensed space, at its own costs and risk, for carrying out activities stated at Point No.

  • Patent License For patent claims including, without limitation, method, process, and apparatus claims which You or Your Affiliates own, control or have the right to grant, now or in the future, You grant to Us a perpetual, worldwide, non-exclusive, transferable, royalty-free, irrevocable patent license, with the right to sublicense these rights to multiple tiers of sublicensees, to make, have made, use, sell, offer for sale, import and otherwise transfer the Contribution and the Contribution in combination with the Material (and portions of such combination). This license is granted only to the extent that the exercise of the licensed rights infringes such patent claims; and provided that this license is conditioned upon compliance with Section 2.3.

  • Developer License We grant you a non-assignable, non-sublicensable, non-exclusive, worldwide right and license for the number of Developer(s) indicated in the Order Form to install the Software on any number of Machines in order to internally use the Software to create, develop and test Applications. For clarity, a single Software license may be re-allocated to another Developer in the event that the original Developer is no longer employed by you or has been assigned to a new role where access to the Software will no longer be required on a permanent basis.

  • Commercialization License Subject to the terms of this Agreement, including without limitation Section 2.2 and Theravance's Co-Promotion rights in Section 5.3.2, Theravance hereby grants to GSK, and GSK accepts, an exclusive license under the Theravance Patents and Theravance Know-How to make, have made, use, sell, offer for sale and import Alliance Products in the Territory.

  • Exclusive License Licensor hereby grants to Licensee and Licensee hereby accepts from Licensor, upon the terms and conditions herein specified, a sole and exclusive license under the Licensed Patent Rights in the Territory, and in the Field of Use to develop, make, have made, import, have imported, use, offer to sell, sell and otherwise commercialize Licensed Product(s).

  • Non-exclusivity, Etc The rights of Indemnitee hereunder will be in addition to any other rights Indemnitee may have under the Charter, the Bylaws or the Maryland General Corporation Law (the "MGCL") or otherwise; provided, however, that to the extent that Indemnitee otherwise would have any greater right to indemnification under any provision of the Charter or Bylaws as in effect on the date hereof, Indemnitee will be deemed to have such greater right hereunder, and provided, further, that to the extent that any change is made to the MGCL (whether by legislative action or judicial decision), the Charter and/or the Bylaws which permits any greater right to indemnification than that provided under this Agreement as of the date hereof, Indemnitee will be deemed to have such greater right hereunder. The Company will not adopt any amendment to the Charter or the Bylaws the effect of which would be to deny, diminish or encumber Indenmitee's right to indemnification under the Charter, the Bylaws, the MGCL or otherwise as applied to any act or failure to act occurring in whole or in part prior to the date upon which the amendment was approved by the Company's Board of Directors and/or its stockholders, as the case may be.

  • Use License If you access the Site via a mobile application, then we grant you a revocable, non- exclusive, non-transferable, limited right to install and use the mobile application on wireless electronic devices owned or controlled by you, and to access and use the mobile application on such devices strictly in accordance with the terms and conditions of this mobile application license contained in these Terms and Conditions. You shall not:

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!